Research libraryMOLEKUL / SOURCE RECORD

Is Cerebrolysin Useful in Psychiatry Disorders?

Florek S, Główczyński P, Badura-Brzoza K, Pudlo R · 2025 · Biomedicines; 2025 Jul

ReviewEnglish abstractSource linked
This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

Study findings

The review found a limited research base for psychiatric applications and discussed possible adjunctive roles.

Population and setting
Scoping review of psychiatric applications
Evidence type
Review
Preparation
See the original report; formulation details require verification.
Source language
eng
Title source
Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

Study limitations

  • Secondary synthesis, not a new clinical trial.
  • Sparse and heterogeneous evidence does not establish routine psychiatric efficacy.
  • Full methods and risk of bias have not been independently assessed.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed record and available abstract checked; full text not reviewed.

Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.3390/biomedicines13071661

Citation and original source

Original source: Florek S, Główczyński P, Badura-Brzoza K, Pudlo R. Is Cerebrolysin Useful in Psychiatry Disorders? Biomedicines; 2025 Jul 2025.

Molekul research summary: https://molekul.io/research/cbl-update-40722733. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards